How do you determine the appropriateness of starting a CGM in patients aged 75 and older with type 2 diabetes on multiple daily insulin injections?

In general, the profile of T2D on MDI is a compelling indication for CGM. The wrinkle here is "age 75 and older". Though our gut instinct is that if the base case is compelling, the case should be stronger for those aged 75 and older. Specifically, avoiding hypoglycemia is critical to keep elders we...

Ideally, CGM should be considered for all patients who are on insulin. The 2026 ADA Standards of Care recommends the use of CGM in all patients at the onset of diabetes, particularly in people using insulin, because CGM has been shown to improve all glucose metrics. Those on insulin should be able t...

CGM is increasingly being used for the treatment of type 2 diabetes. A recent systematic review and meta-analysis showed that CGM, as compared to self-glucose monitoring (SMBG), is associated with improvements in glycemic control. In addition, it was associated with increased Time in range (TIR) and...